Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02895334 · ClinicalTrials.gov registry record · NA

MyHeartBaby: An Initial Evaluation of the MyHeartBaby Psychosocial Telemedicine Program

A NA study of Congenital Heart Disease, sponsored by Emory University.

Completed
Registry status
NA
Development phase
25
Enrollment target
1
Study location

NCT02895334 is a NA study of Congenital Heart Disease that has completed, run by Emory University. The registered enrollment target is 25 participants, below the 474-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02895334, a NA study of Congenital Heart Disease, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

This study will conduct an initial clinical evaluation of this support program to examine its impact on reducing caregiver stress, increasing confidence in daily feeding, and improving weight-for-age growth percentiles in infants with Congenital Heart Disease (CHD).

Conditions Studied

Interventions

  • BEHAVIORAL MyHeartBaby Program

Study Locations (1)

Georgia

  • Children's Healthcare of Atlanta - Atlanta

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2015-07
Est. Completion 2017-04-07
Phase NA

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT02895334

The ClinicalTrials.gov registry entry for NCT02895334 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 474-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (95% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Congenital Heart Disease appearing as the primary indexed condition, and to 1 intervention - of which MyHeartBaby Program is the first listed.

NCT02895334 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT02895334 about?

NCT02895334 is a clinical study titled "MyHeartBaby: An Initial Evaluation of the MyHeartBaby Psychosocial Telemedicine Program". This study will conduct an initial clinical evaluation of this support program to examine its impact on reducing caregiver stress, increasing confidence in daily feeding, and improving weight-for-age growth percentiles in infants with Congenital Heart Disease (CHD).

What is the current status of trial NCT02895334?

This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2015-07. Estimated completion is 2017-04-07.

What conditions does trial NCT02895334 study?

This clinical trial studies the following conditions: Congenital Heart Disease.

What interventions are being tested in trial NCT02895334?

The interventions under investigation include: MyHeartBaby Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT02895334?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02895334 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Congenital Heart Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.